                               SEQUENCE LISTING

<110> VAXIN INC.
 
<120> RAPID AND PROLONGED IMMUNOLOGIC-THERAPEUTIC

<130> 43109.99.2021

<140> PCT/US2012/029927
<141> 2012-03-21

<150> 61/568,054
<151> 2011-12-07

<150> 61/454,819
<151> 2011-03-21

<160> 2     

<170> PatentIn version 3.5

<210> 1
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
cacaggtacc gccaccatga aggccaagct g                                      31


<210> 2
<211> 37
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
gagtctagat tatcagccga acaggcctct gctctgg                                37


